DII has been reported to have association with numerous plasma inflammatory markers (CRP and IL6) and multiple health outcomes (stoke, depression, CVDs, metabolic risk markers, cancer and all-cause and specific-cause mortality) [53]. This evidence concerns the gene CRP and depressive symptom measurement.